Sam Lidman: Daily

quantilope's AI, quinn, now powers the entire research process, ushering in a new 'Do-it-with-quinn' era and reshaping the role of the researcher.

A Fort Worth dentist's new non-surgical therapy aims to reshape child development by addressing the hidden link between airway health, sleep, and behavior.

RioCan posts strong 2025 results with near-full occupancy, but massive valuation losses and a development strategy shift reveal a complex picture.

A landmark partnership in Greensboro creates a first-of-its-kind pathway for students to gain tech skills and college credit, tackling the state's talent gap.

Robinhood's RVI fund offers retail investors access to giants like Stripe for $25 a share. Is it a revolution in access or a high-risk gamble?

New research reveals near-universal AI use among marketers, but finds consumers prioritize content quality over disclosure, elevating the need for human oversight.

Facing financial headwinds, the timeshare giant appoints a new CEO and COO with a bold, performance-based plan to revitalize growth and shareholder value.

A Pittsburgh agency's five-year commitment to Penn State's ad program highlights a strategic investment in real-world student experience and future talent.

A new report crowns a Chicago interchange America's worst traffic chokepoint, revealing how worsening gridlock costs the U.S. economy $109 billion annually.

A new five-year deal will leverage patient-derived stem cells and AI to revolutionize the hunt for Alzheimer's cures, aiming to bridge a critical gap.

A new network of local recycling facilities aims to solve the e-waste gap for small businesses, boosting data security and domestic materials recovery.

Prestigious toxicology awards recognize UL Research Institutes' vital work on vaping health risks and innovative methods for assessing chemical safety.

The major CRO acquisition deepens Worldwide's oncology and FSP capabilities, signaling a strategic move in the consolidating clinical research market.

LEX Diagnostics' newly FDA-cleared VELO system delivers lab-quality PCR results for flu & COVID in under 10 minutes, set to revolutionize point-of-care testing.

Spin Master's interactive T. rex wins Toy of the Year, while the industry raises over $1M for charity and honors new Hall of Fame legends at the 2026 TOTY Awards.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

With a year of strong growth, key partnerships, and pipeline progress, all eyes are on ALK's upcoming annual results for 2025.

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

Škoda is turning charging stops into arcade sessions, adding AirConsole gaming and an exclusive Tetris experience to its electric vehicles in Europe.

Facing a national crisis of long waits for autism diagnosis, a new free online tool from Catalight hopes to connect families with care in days, not months.